Disciplined Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-75
Closed -$1.56K 1097
2023
Q2
$1.56K Buy
75
+10
+15% +$217 ﹤0.01% 760
2023
Q1
$1.53K Sell
65
-10
-13% -$269 ﹤0.01% 789
2022
Q4
$2.1K Buy
75
+11
+17% +$281 ﹤0.01% 600
2022
Q3
$1K Sell
64
-16
-20% -$483 ﹤0.01% 1016
2022
Q2
$3K Buy
80
+11
+16% +$385 ﹤0.01% 567
2022
Q1
$2K Buy
69
+21
+44% +$718 ﹤0.01% 758
2021
Q4
$1K Hold
48
﹤0.01% 475
2021
Q3
$2K Hold
48
﹤0.01% 401
2021
Q2
$1K Buy
+48
New +$1.58K ﹤0.01% 410

Other funds holding OGN

Disciplined Investments's OGN Position: Q3 2023 in Review

Disciplined Investments sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 75 shares — an estimated $1.56K sold.

Disciplined Investments first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $3K in Q2 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Disciplined Investments reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 75 Organon & Co shares in Q3 2023, an estimated $1.56K.
  • Disciplined Investments first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Disciplined Investments's Organon & Co position peaked at $3K in Q2 2022.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.